WASHINGTON--Patients with type 1 diabetes who use Medtronic's MiniMedTM 670G insulin pump system are able to maintain blood glucose levels in the targeted range over 71% of the time, according to a ...
The FDA announced that Medtronic expanded two recalls relating to the MiniMed 600 series of insulin pumps and MiniMed 508 remote controllers. Both were designated by the agency as Class I, the most ...
The MiniMed 670G hybrid closed-loop insulin delivery system (Medtronic) offers the potential for improved blood glucose control for people with type 1 diabetes, but clinicians should anticipate the ...
This image provided by Medtronic shows its MiniMed 670G system. Federal regulators have approved a first-of-a-kind "artificial pancreas," a device that can help some diabetes patients manage their ...
GOLDEN VALLEY, Minn. — According to the U.S. Food and Drug Administration, Medtronic is recalling its MiniMed 600 series insulin pumps. According to the FDA, the recall not only affects individuals ...
CNN — Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on ...
Retainer rings on its MiniMed 630G and MiniMed 670G insulin pumps have been breaking, which can lead to a health hazard for users. The retaining ring is responsible for locking the insulin reservoir ...
Welcome to the age of the artificial pancreas – sort of. True, Medtronic’s (NYSE:MDT) MiniMed 670G has become the first device that automatically administers insulin to gain FDA approval, and some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback